학술논문
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80
Document Type
Article
Author
Source
In: Nature Cancer . (Nature Cancer, December 2022, 3(12):1513-1533)
Subject
Language
English
ISSN
26621347